Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Incidence and predictors of 1-year mortality among 9236 breast cancer patients referred for adjuvant chemotherapy Future Oncology
ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials International Journal of Colorectal Disease
Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease Strahlentherapie und Onkologie
Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials The Breast
Outcomes of metastatic breast cancer patients in relationship to disease‐free interval following primary treatment of localized disease; a pooled analysis of two clinical trials The Breast Journal
Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study The Clinical Respiratory Journal
Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel - A pooled analysis of 3 randomized studies Urologic Oncology: Seminars and Original Investigations
Outcomes of metastatic colorectal cancer patients in relationship to prior and concurrent antibiotics use; individual patient data analysis of three clinical trials Clinical and Translational Oncology
Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer The Oncologist
Second-Line Erlotinib After Failure of Pemetrexed-Containing Chemotherapy in Advanced non-Small Cell Lung Cancer (NSCLC): Real-World Effectiveness, Safety and Tolerability PLOS ONE
PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients Frontiers in Immunology
Leveraging external data in the design and analysis of clinical trials in neuro-oncology Lancet Oncology
Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials The Oncologist
Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research

Pages